OWM
NVO

OneAscent Wealth Management’s Novo Nordisk NVO Stock Holding History

OneAscent Wealth Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4,598
Closed -$257K – 229
2021
Q4 		$257K Buy
+4,598
New +$249K 0.64% 67
2021
Q1 		$287K Buy
8,518
+1,038
+14% +$37K 0.12% 171
2020
Q4 		$261K Buy
+7,480
New +$259K 0.12% 175

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

OneAscent Wealth Management's NVO Position: Q1 2022 in Review

OneAscent Wealth Management sold out of Novo Nordisk (NVO) in Q1 2022, closing a stake of 4,598 shares — an estimated $257K sold.

OneAscent Wealth Management first reported a position in NVO in Q4 2020 and held it in 3 quarters. The position peaked at $287K in Q1 2021. 902 funds tracked by Wall St. Rank hold NVO as of Q1 2022.

  • OneAscent Wealth Management reported no remaining Novo Nordisk position as of Q1 2022 after selling out during the quarter.
  • OneAscent Wealth Management sold 4,598 Novo Nordisk shares in Q1 2022, an estimated $257K.
  • OneAscent Wealth Management first reported a position in Novo Nordisk in Q4 2020 and held it in 3 quarters.
  • OneAscent Wealth Management's Novo Nordisk position peaked at $287K in Q1 2021.
  • 902 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2022.

Based on OneAscent Wealth Management's 13F filing for Q1 2022, filed 12 May 2022.